戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              FAIRE (formaldehyde-assisted isolation of regulatory ele
2                                              FAIRE has low technical variability, which allows its us
3                                              FAIRE has utility as a positive selection for genomic re
4                                              FAIRE induction was universally decreased by Brg-1 deple
5                                              FAIRE performed in human cells strongly enriches DNA coi
6                The combination of DNaseI and FAIRE is more effective than either assay alone in ident
7 erse human cell types, we used DNase-seq and FAIRE-seq (Formaldehyde Assisted Isolation of Regulatory
8 bulk samples such as ChIP-seq, DNase-seq and FAIRE-seq cannot analyze samples with small numbers of c
9 detected by techniques such as DNase-seq and FAIRE-seq.
10              Regulatory elements enriched by FAIRE have high concordance with those identified by nuc
11 latory elements to extract protein-free DNA (FAIRE) and the MNase-mediated purification of mononucleo
12 de-assisted isolation of regulatory element (FAIRE)-sequencing.
13 e-Assisted Isolation of Regulatory Elements (FAIRE) procedure and use it to determine the rate of cro
14 e-assisted isolation of regulatory elements (FAIRE) quantitative PCR and chromatin immunoprecipitatio
15 e-assisted isolation of regulatory elements (FAIRE) revealed chromatin conformation changes that were
16 e-assisted isolation of regulatory elements (FAIRE) to map open chromatin during the transition from
17 e-assisted isolation of regulatory elements (FAIRE), a chemical method to enrich for nucleosome-deple
18 e-assisted isolation of regulatory elements (FAIRE), does not affect the accessible chromatin signal.
19 e-assisted isolation of regulatory elements (FAIRE).
20 e FAIRE data were compared with whole-embryo FAIRE data.
21 ong midline FAIRE peak and weak whole-embryo FAIRE peak overlap with known midline enhancers and prov
22 ith, but is distinct from, that observed for FAIRE and DNase I hypersensitive sites.
23               Supporting this notion, global FAIRE sequencing (seq) data indicated an enrichment of s
24              We looked at dynamic changes in FAIRE signals during GR activation specifically at regio
25  GR binding regions demonstrate increases in FAIRE signal in response to ligand.
26 n of this method of enhanced cavitation into FAIRE offers the potential for extending chromatin acces
27  rs7903146 showed allelic imbalance in islet FAIRE signals and that the variant alters enhancer activ
28    Midline enhancer fragments with a midline FAIRE peak tend to be near midline-expressed genes, wher
29  whereas midline enhancers without a midline FAIRE peak were often distant from midline-expressed gen
30  regions of the genome with a strong midline FAIRE peak and weak whole-embryo FAIRE peak overlap with
31  midline cells was performed and the midline FAIRE data were compared with whole-embryo FAIRE data.
32                                Comparison of FAIRE-seq data from islets to that from five non-islet c
33  Evidence for cell-type-specific patterns of FAIRE enrichment is also presented.
34 map "open chromatin." Over 870,000 DNaseI or FAIRE sites, which correspond tightly to nucleosome-depl
35                                          Our FAIRE results were compared with DNA-methylation analysi
36                             In addition, our FAIRE-seq analysis allowed us to identify regulatory ele
37                                   To perform FAIRE, chromatin is crosslinked with formaldehyde in viv
38                  NCOR1 and H3K9me3 ChIP-Seq, FAIRE-seq and DNA CpG methylation interactions were rela
39 ulatory regions in DNA (DNase-seq, ChIP-seq, FAIRE-seq, ATAC-seq).
40 hort-read sequencing technologies (ChIP-seq, FAIRE-seq, MNase-Seq, ...) and offers innovative approac
41 ble chromatin landscape including DNase-seq, FAIRE-seq and ATAC-seq.
42 nomic assays, including ChIP-seq, DNase-seq, FAIRE-seq and others.
43  data from a variety of ChIP-seq, DNase-seq, FAIRE-seq, and ATAC-seq experiments, we show that our we
44 s) combined with next-generation sequencing (FAIRE-seq) to identify specific changes in chromatin acc
45 ents followed by next-generation sequencing (FAIRE-seq) to map regions of open chromatin in three pri
46 nts coupled with high-throughput sequencing (FAIRE-seq).
47 ority GR-responsive regions shared a similar FAIRE signal in the basal chromatin state, suggesting a
48                               In this study, FAIRE-seq on FACS-purified midline cells was performed a
49   Using 548 ENCODE ChIP-seq and six targeted FAIRE-seq samples, we show that BaalChIP effectively cor
50 me-depleted DNA from human chromatin, termed FAIRE (Formaldehyde-Assisted Isolation of Regulatory Ele
51 ion of cis-regulatory elements and show that FAIRE-seq can guide the identification of regulatory var
52                              We modified the FAIRE procedure to allow us to examine chromatin accessi
53 at drive midline expression in vivo with the FAIRE data.